Department of Environmental Health Sciences, University of Michigan School of Public Health, Ann Arbor, MI, USA.
Program on Reproductive Health and the Environment, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, School of Medicine, San Francisco, CA, USA.
J Expo Sci Environ Epidemiol. 2022 May;32(3):374-383. doi: 10.1038/s41370-021-00408-3. Epub 2022 Jan 5.
Phthalates are used in the manufacturing of consumer products, resulting in ubiquitous human exposure to phthalate mixtures. Previous work has suggested that phthalates display endocrine-disrupting capabilities, and exposure is associated with early delivery.
To assess mediating effects of hormone concentrations on associations between phthalate mixtures and preterm birth (PTB).
Repeated urinary phthalates and serum hormones were measured among 1011 women in the PROTECT Puerto Rico birth cohort from 2011-2019. We utilized ridge regression to create phthalate environmental risk scores (ERS), which represent weighted summaries of total phthalate exposure. Mediation analyses were conducted on a subset of 705 women. We additionally conducted fetal sex-specific analyses.
Free thyroxine (FT4) mediated 9.6% of the association between high molecular weight (HMW) ERS at 18 weeks and reduced gestational age at delivery (95%CI:1.07-29.9). Progesterone at 26 weeks mediated 21.1% and 16.2% of the association between HMW ERS at 18 and 22 weeks, and spontaneous PTB, respectively. Among male fetuses, corticotropin releasing hormone (CRH) at 18 weeks mediated 28.2% of the association between low molecular weight ERS and spontaneous PTB.
We provide introductory evidence of hormone disruption on the causal pathway between phthalate exposure and early delivery. We also show differences by fetal sex, but larger sample size is necessary to validate our findings.
This study provides introductory evidence that an alteration of hormone concentrations occurs on the causal pathway between gestational phthalate mixture exposure and subsequent PTB. In addition to the novel application of repeated biomarker measurements and mixtures methods in causal mediation analyses, we also explored differences between classes of phthalate compounds and between fetal sexes. We show that differential endocrine pathways may be disrupted with exposures to low versus HMW phthalate compounds, and that pregnancies with a male fetus may be more susceptible to endocrine disruption than those with a female fetus.
邻苯二甲酸酯用于制造消费品,导致人类普遍接触邻苯二甲酸酯混合物。先前的研究表明,邻苯二甲酸酯具有内分泌干扰能力,其暴露与早产有关。
评估激素浓度对邻苯二甲酸酯混合物与早产(PTB)之间关联的中介作用。
在 2011 年至 2019 年期间,PROTECT 波多黎各出生队列中的 1011 名女性中重复测量了尿液邻苯二甲酸酯和血清激素。我们利用脊回归创建了邻苯二甲酸酯环境风险评分(ERS),该评分代表了总邻苯二甲酸酯暴露的加权总和。在 705 名女性的子集中进行了中介分析。我们还进行了胎儿性别特异性分析。
游离甲状腺素(FT4)介导了 18 周时高分子量(HMW)ERS 与分娩时胎龄减少之间 9.6%的关联(95%CI:1.07-29.9)。26 周时的孕激素分别介导了 18 周和 22 周时 HMW ERS 与自发性 PTB 之间 21.1%和 16.2%的关联。在男性胎儿中,18 周时的促肾上腺皮质激素释放激素(CRH)介导了低分子量 ERS 与自发性 PTB 之间 28.2%的关联。
我们提供了激素破坏在邻苯二甲酸酯暴露与早期分娩之间因果关系途径上的初步证据。我们还显示了胎儿性别之间的差异,但需要更大的样本量来验证我们的发现。
这项研究提供了初步证据,表明在妊娠期间邻苯二甲酸酯混合物暴露与随后的 PTB 之间的因果关系途径上发生了激素浓度的改变。除了在因果中介分析中重复生物标志物测量和混合物方法的新颖应用外,我们还探索了不同类别的邻苯二甲酸酯化合物和胎儿性别之间的差异。我们表明,低分子量与高分子量邻苯二甲酸酯化合物的暴露可能会破坏不同的内分泌途径,并且与女性胎儿相比,怀有男性胎儿的妊娠可能更容易受到内分泌干扰。